{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:34:43Z","timestamp":1783492483341,"version":"3.55.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ajog.2018.01.036","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T01:23:01Z","timestamp":1517534581000},"page":"504.e1-504.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Pharmacy-level barriers to implementing expedited partner therapy in Baltimore, Maryland"],"prefix":"10.1016","volume":"218","author":[{"given":"Jennifer Z.","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa P.","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7546-7727","authenticated-orcid":false,"given":"Jenell S.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2018.01.036_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/sti.75.1.3","article-title":"From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection","volume":"75","author":"Fleming","year":"1999","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ajog.2018.01.036_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9378(97)80020-8","article-title":"Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease","volume":"176","author":"Hillis","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.01.036_bib5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/OLQ.0b013e3181a2a933","article-title":"Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature","volume":"26","author":"Hosenfeld","year":"2009","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ajog.2018.01.036_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11908-010-0159-3","article-title":"Expedited partner treatment for sexually transmitted infections: an update","volume":"13","author":"Kissinger","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.ajog.2018.01.036_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00007435-200301000-00011","article-title":"Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial","volume":"30","author":"Schillinger","year":"2003","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ajog.2018.01.036_bib8","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/OLQ.0b013e3181e1a296","article-title":"Expedited partner therapy: a robust intervention","volume":"37","author":"Shiely","year":"2010","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ajog.2018.01.036_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/OLQ.0000000000000511","article-title":"The impact of prescriptions on sex partner treatment using expedited partner therapy for Chlamydia trachomatis infection, New York City, 2014\u20132015","volume":"43","author":"Oliver","year":"2016","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ajog.2018.01.036_bib10","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1097\/OLQ.0000000000000399","article-title":"The expedited partner therapy continuum: a conceptual framework to guide programmatic efforts to increase partner treatment","volume":"43","author":"Schillinger","year":"2016","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ajog.2018.01.036_bib12","unstructured":"EvergreenHealth. Maryland 2015 Pharmacy Directory. Available at: https:\/\/www.evergreenmd.org\/wp-content\/uploads\/2015\/01\/EHAML201518_PharmacyList_d11.pdf. Accessed February 11, 2017."},{"key":"10.1016\/j.ajog.2018.01.036_bib20","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.japh.2016.12.077","article-title":"Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015","volume":"57","author":"Stopka","year":"2017","journal-title":"J\u00a0Am Pharm Assoc"},{"key":"10.1016\/j.ajog.2018.01.036_bib21","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1377\/hlthaff.2013.1397","article-title":"\u2018Pharmacy deserts\u2019 are prevalent in Chicago\u2019s predominantly minority communities, raising medication access concerns","volume":"33","author":"Qato","year":"2014","journal-title":"Health Affairs"},{"key":"10.1016\/j.ajog.2018.01.036_bib23","article-title":"Impact of expedited partner therapy (EPT) implementation on chlamydia incidence in the USA","author":"Mmeje","year":"2017","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ajog.2018.01.036_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/OLQ.0000000000000520","article-title":"Pharmacists\u2019 knowledge and practices surrounding expedited partner therapy for chlamydia trachomatis, New York City, 2012 and 2014","volume":"43","author":"Reid","year":"2016","journal-title":"Sex Transm Dis"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937818300851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937818300851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:17:46Z","timestamp":1757589466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937818300851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0002937818300851"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2018.01.036","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacy-level barriers to implementing expedited partner therapy in Baltimore, Maryland","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2018.01.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}